POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.
High Impact

Proposed 'MAPS Act' to Map U.S. Pharmaceutical Supply Chains

Original title: Text of Senate Amendment 6067

Record date · June 24, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

Senate Amendment 6067, known as the 'MAPS Act,' would require the Department of Health and Human Services to map pharmaceutical supply chains for critical drugs and biological products. The bill aims to identify vulnerabilities related to national security and drug shortages, while requiring the Department of Defense to report on its purchases of drugs sourced from the People's Republic of China.

Why it matters

This amendment would create new federal requirements for tracking the origin of critical medications and reporting on foreign-sourced drugs used by the military, potentially impacting how the government manages pharmaceutical procurement and supply chain security.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Department of Health and Human Services

The agency is tasked with mapping pharmaceutical supply chains and coordinating with other federal departments.

Directly affected

Department of Defense

The agency must produce biannual reports on its pharmaceutical procurement from the People's Republic of China.

Directly affected

Pharmaceutical manufacturers

Manufacturers may be subject to increased data collection and reporting requirements regarding their supply chains and production locations.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is the purpose of the MAPS Act?
The act aims to map pharmaceutical supply chains to identify vulnerabilities that could threaten national security or lead to drug shortages.
What information will the Department of Defense have to report?
The Department of Defense must report every 180 days on any drugs it purchased that contain ingredients from, or were manufactured in, the People's Republic of China.
Will this act expose confidential business information?
The act includes provisions to ensure that information exchanged between agencies remains protected as trade secrets or .

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Increased Focus on Foreign Sourcing

The amendment signals a shift toward mandatory transparency regarding the reliance of the U.S. military on pharmaceutical products sourced from the People's Republic of China.

Connected Entities

Department of Defense, Ms. Slotkin, Timothy Kaine and 6 more
OrganizationDepartment of Defense“Agency required to report on drug purchases from China”Map →
PersonMs. Slotkin“Senator who co-sponsored the amendment”Map →
PersonTimothy Kaine“Senator who co-sponsored the amendment”Map →
PersonMr. Lankford“Senator who co-sponsored the amendment”Map →
PersonMr. Peters“Senator who submitted the amendment”Map →
OrganizationDepartment of Health and Human Services“Primary agency responsible for mapping supply chains”Map →
locationPeople's Republic of China“Country of origin for pharmaceutical supply chain reporting”Map →
PersonMr. King“Senator who co-sponsored the amendment”Map →
PersonMr. Cotton“Senator who co-sponsored the amendment”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record